Coagulation Factor Deficiency
7
2
2
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
14%
1 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (7)
SWIFT - SWIss Factor XIII Trial in PPH
Longitudinal Cohort of Thrombosis and Hemostasis Diseases
Alterations in Coagulation Factor Levels in Patients With End Stage Liver Disease
Estimation of Coagulation Factor XIII Activity Based on the Initial Plasma Fibrinogen Level in Trauma
Effect of Vitamin K in Critically Ill Patients
Evaluation of Coagulation Factors and Point-of-care Devices During Veno-venous ECMO Therapy
Cross-sectional Study on Prevalence of Coagulation Factors Deficiency in Assiut University Children Hospital